nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0625	0.0849	CbGbCtD
Fluvoxamine—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0536	0.0729	CbGbCtD
Fluvoxamine—CYP1A1—Dexamethasone—ankylosing spondylitis	0.0519	0.0706	CbGbCtD
Fluvoxamine—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0416	0.0565	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0416	0.0565	CbGbCtD
Fluvoxamine—CYP2C19—Prednisone—ankylosing spondylitis	0.0403	0.0548	CbGbCtD
Fluvoxamine—CYP2E1—Dexamethasone—ankylosing spondylitis	0.0401	0.0545	CbGbCtD
Fluvoxamine—CYP2B6—Dexamethasone—ankylosing spondylitis	0.0396	0.0538	CbGbCtD
Fluvoxamine—ABCB1—Betamethasone—ankylosing spondylitis	0.0349	0.0474	CbGbCtD
Fluvoxamine—ABCB1—Prednisolone—ankylosing spondylitis	0.0344	0.0468	CbGbCtD
Fluvoxamine—ABCB1—Prednisone—ankylosing spondylitis	0.0325	0.0442	CbGbCtD
Fluvoxamine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0321	0.0437	CbGbCtD
Fluvoxamine—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0312	0.0424	CbGbCtD
Fluvoxamine—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0251	0.0342	CbGbCtD
Fluvoxamine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0244	0.0331	CbGbCtD
Fluvoxamine—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0209	0.0284	CbGbCtD
Fluvoxamine—CYP3A4—Betamethasone—ankylosing spondylitis	0.0209	0.0284	CbGbCtD
Fluvoxamine—CYP3A4—Prednisolone—ankylosing spondylitis	0.0206	0.028	CbGbCtD
Fluvoxamine—ABCB1—Dexamethasone—ankylosing spondylitis	0.0203	0.0276	CbGbCtD
Fluvoxamine—CYP3A4—Prednisone—ankylosing spondylitis	0.0195	0.0265	CbGbCtD
Fluvoxamine—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0191	0.026	CbGbCtD
Fluvoxamine—ABCB1—Methotrexate—ankylosing spondylitis	0.0163	0.0222	CbGbCtD
Fluvoxamine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0122	0.0165	CbGbCtD
Fluvoxamine—Sweating—Methotrexate—ankylosing spondylitis	0.000212	0.000802	CcSEcCtD
Fluvoxamine—Infection—Methylprednisolone—ankylosing spondylitis	0.000212	0.000801	CcSEcCtD
Fluvoxamine—Haematuria—Methotrexate—ankylosing spondylitis	0.000211	0.000798	CcSEcCtD
Fluvoxamine—Shock—Triamcinolone—ankylosing spondylitis	0.00021	0.000795	CcSEcCtD
Fluvoxamine—Insomnia—Prednisolone—ankylosing spondylitis	0.00021	0.000795	CcSEcCtD
Fluvoxamine—Alopecia—Prednisone—ankylosing spondylitis	0.00021	0.000794	CcSEcCtD
Fluvoxamine—Shock—Methylprednisolone—ankylosing spondylitis	0.00021	0.000793	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000209	0.000791	CcSEcCtD
Fluvoxamine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000209	0.00079	CcSEcCtD
Fluvoxamine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000209	0.000789	CcSEcCtD
Fluvoxamine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000209	0.000789	CcSEcCtD
Fluvoxamine—Epistaxis—Methotrexate—ankylosing spondylitis	0.000209	0.000789	CcSEcCtD
Fluvoxamine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000209	0.000789	CcSEcCtD
Fluvoxamine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000208	0.000788	CcSEcCtD
Fluvoxamine—Mental disorder—Prednisone—ankylosing spondylitis	0.000208	0.000787	CcSEcCtD
Fluvoxamine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000208	0.000787	CcSEcCtD
Fluvoxamine—Malnutrition—Prednisone—ankylosing spondylitis	0.000207	0.000782	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000207	0.000781	CcSEcCtD
Fluvoxamine—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000206	0.000781	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000206	0.000779	CcSEcCtD
Fluvoxamine—Convulsion—Dexamethasone—ankylosing spondylitis	0.000206	0.000778	CcSEcCtD
Fluvoxamine—Convulsion—Betamethasone—ankylosing spondylitis	0.000206	0.000778	CcSEcCtD
Fluvoxamine—Hypertension—Betamethasone—ankylosing spondylitis	0.000205	0.000775	CcSEcCtD
Fluvoxamine—Hypertension—Dexamethasone—ankylosing spondylitis	0.000205	0.000775	CcSEcCtD
Fluvoxamine—Myalgia—Betamethasone—ankylosing spondylitis	0.000202	0.000765	CcSEcCtD
Fluvoxamine—Myalgia—Dexamethasone—ankylosing spondylitis	0.000202	0.000765	CcSEcCtD
Fluvoxamine—Anxiety—Dexamethasone—ankylosing spondylitis	0.000202	0.000762	CcSEcCtD
Fluvoxamine—Anxiety—Betamethasone—ankylosing spondylitis	0.000202	0.000762	CcSEcCtD
Fluvoxamine—Discomfort—Betamethasone—ankylosing spondylitis	0.0002	0.000755	CcSEcCtD
Fluvoxamine—Discomfort—Dexamethasone—ankylosing spondylitis	0.0002	0.000755	CcSEcCtD
Fluvoxamine—Haemoglobin—Methotrexate—ankylosing spondylitis	0.0002	0.000755	CcSEcCtD
Fluvoxamine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000199	0.000753	CcSEcCtD
Fluvoxamine—Pain—Prednisolone—ankylosing spondylitis	0.000199	0.000751	CcSEcCtD
Fluvoxamine—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000199	0.000751	CcSEcCtD
Fluvoxamine—Hepatitis—Methotrexate—ankylosing spondylitis	0.000199	0.000751	CcSEcCtD
Fluvoxamine—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000197	0.000745	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000196	0.000742	CcSEcCtD
Fluvoxamine—Vision blurred—Prednisone—ankylosing spondylitis	0.000195	0.000737	CcSEcCtD
Fluvoxamine—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000195	0.000736	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000195	0.000736	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000194	0.000734	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000194	0.000733	CcSEcCtD
Fluvoxamine—Oedema—Dexamethasone—ankylosing spondylitis	0.000194	0.000733	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000194	0.000733	CcSEcCtD
Fluvoxamine—Oedema—Betamethasone—ankylosing spondylitis	0.000194	0.000733	CcSEcCtD
Fluvoxamine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000193	0.000731	CcSEcCtD
Fluvoxamine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000193	0.000729	CcSEcCtD
Fluvoxamine—Infection—Betamethasone—ankylosing spondylitis	0.000193	0.000728	CcSEcCtD
Fluvoxamine—Infection—Dexamethasone—ankylosing spondylitis	0.000193	0.000728	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000192	0.000726	CcSEcCtD
Fluvoxamine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000192	0.000725	CcSEcCtD
Fluvoxamine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000191	0.000724	CcSEcCtD
Fluvoxamine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000191	0.000724	CcSEcCtD
Fluvoxamine—Visual impairment—Methotrexate—ankylosing spondylitis	0.000191	0.000724	CcSEcCtD
Fluvoxamine—Anaemia—Prednisone—ankylosing spondylitis	0.000191	0.000723	CcSEcCtD
Fluvoxamine—Shock—Betamethasone—ankylosing spondylitis	0.000191	0.000721	CcSEcCtD
Fluvoxamine—Shock—Dexamethasone—ankylosing spondylitis	0.000191	0.000721	CcSEcCtD
Fluvoxamine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00019	0.00072	CcSEcCtD
Fluvoxamine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00019	0.000719	CcSEcCtD
Fluvoxamine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00019	0.000719	CcSEcCtD
Fluvoxamine—Agitation—Prednisone—ankylosing spondylitis	0.00019	0.000719	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00019	0.000718	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00019	0.000718	CcSEcCtD
Fluvoxamine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000189	0.000715	CcSEcCtD
Fluvoxamine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000189	0.000715	CcSEcCtD
Fluvoxamine—Angioedema—Prednisone—ankylosing spondylitis	0.000189	0.000715	CcSEcCtD
Fluvoxamine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000188	0.000711	CcSEcCtD
Fluvoxamine—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000188	0.00071	CcSEcCtD
Fluvoxamine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000188	0.00071	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000187	0.000709	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000187	0.000709	CcSEcCtD
Fluvoxamine—Malaise—Prednisone—ankylosing spondylitis	0.000187	0.000705	CcSEcCtD
Fluvoxamine—Vertigo—Prednisone—ankylosing spondylitis	0.000186	0.000703	CcSEcCtD
Fluvoxamine—Eye disorder—Methotrexate—ankylosing spondylitis	0.000186	0.000702	CcSEcCtD
Fluvoxamine—Syncope—Prednisone—ankylosing spondylitis	0.000185	0.000701	CcSEcCtD
Fluvoxamine—Tinnitus—Methotrexate—ankylosing spondylitis	0.000185	0.0007	CcSEcCtD
Fluvoxamine—Anorexia—Betamethasone—ankylosing spondylitis	0.000185	0.000699	CcSEcCtD
Fluvoxamine—Anorexia—Dexamethasone—ankylosing spondylitis	0.000185	0.000699	CcSEcCtD
Fluvoxamine—Urticaria—Prednisolone—ankylosing spondylitis	0.000185	0.000698	CcSEcCtD
Fluvoxamine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000184	0.000697	CcSEcCtD
Fluvoxamine—Fatigue—Triamcinolone—ankylosing spondylitis	0.000184	0.000696	CcSEcCtD
Fluvoxamine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000184	0.000695	CcSEcCtD
Fluvoxamine—Pain—Triamcinolone—ankylosing spondylitis	0.000183	0.000691	CcSEcCtD
Fluvoxamine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000182	0.000687	CcSEcCtD
Fluvoxamine—Hypotension—Betamethasone—ankylosing spondylitis	0.000181	0.000685	CcSEcCtD
Fluvoxamine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000181	0.000685	CcSEcCtD
Fluvoxamine—Angiopathy—Methotrexate—ankylosing spondylitis	0.00018	0.000681	CcSEcCtD
Fluvoxamine—Convulsion—Prednisone—ankylosing spondylitis	0.000179	0.000678	CcSEcCtD
Fluvoxamine—Hypertension—Prednisone—ankylosing spondylitis	0.000179	0.000675	CcSEcCtD
Fluvoxamine—Chills—Methotrexate—ankylosing spondylitis	0.000178	0.000674	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000177	0.000668	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000177	0.000668	CcSEcCtD
Fluvoxamine—Arthralgia—Prednisone—ankylosing spondylitis	0.000176	0.000666	CcSEcCtD
Fluvoxamine—Myalgia—Prednisone—ankylosing spondylitis	0.000176	0.000666	CcSEcCtD
Fluvoxamine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000176	0.000666	CcSEcCtD
Fluvoxamine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000176	0.000664	CcSEcCtD
Fluvoxamine—Anxiety—Prednisone—ankylosing spondylitis	0.000175	0.000664	CcSEcCtD
Fluvoxamine—Alopecia—Methotrexate—ankylosing spondylitis	0.000175	0.000664	CcSEcCtD
Fluvoxamine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000175	0.000663	CcSEcCtD
Fluvoxamine—Insomnia—Betamethasone—ankylosing spondylitis	0.000175	0.000663	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000174	0.000659	CcSEcCtD
Fluvoxamine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000174	0.000658	CcSEcCtD
Fluvoxamine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000174	0.000658	CcSEcCtD
Fluvoxamine—Discomfort—Prednisone—ankylosing spondylitis	0.000174	0.000658	CcSEcCtD
Fluvoxamine—Mental disorder—Methotrexate—ankylosing spondylitis	0.000174	0.000658	CcSEcCtD
Fluvoxamine—Malnutrition—Methotrexate—ankylosing spondylitis	0.000173	0.000654	CcSEcCtD
Fluvoxamine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000171	0.000647	CcSEcCtD
Fluvoxamine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000171	0.000645	CcSEcCtD
Fluvoxamine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000171	0.000645	CcSEcCtD
Fluvoxamine—Urticaria—Triamcinolone—ankylosing spondylitis	0.00017	0.000642	CcSEcCtD
Fluvoxamine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000169	0.00064	CcSEcCtD
Fluvoxamine—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000169	0.00064	CcSEcCtD
Fluvoxamine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000169	0.000639	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000169	0.000638	CcSEcCtD
Fluvoxamine—Oedema—Prednisone—ankylosing spondylitis	0.000169	0.000638	CcSEcCtD
Fluvoxamine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000169	0.000637	CcSEcCtD
Fluvoxamine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000169	0.000637	CcSEcCtD
Fluvoxamine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000169	0.000637	CcSEcCtD
Fluvoxamine—Infection—Prednisone—ankylosing spondylitis	0.000168	0.000634	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000167	0.000633	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000167	0.000633	CcSEcCtD
Fluvoxamine—Back pain—Methotrexate—ankylosing spondylitis	0.000167	0.000632	CcSEcCtD
Fluvoxamine—Fatigue—Betamethasone—ankylosing spondylitis	0.000167	0.000632	CcSEcCtD
Fluvoxamine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000167	0.000632	CcSEcCtD
Fluvoxamine—Shock—Prednisone—ankylosing spondylitis	0.000166	0.000628	CcSEcCtD
Fluvoxamine—Pain—Dexamethasone—ankylosing spondylitis	0.000166	0.000627	CcSEcCtD
Fluvoxamine—Pain—Betamethasone—ankylosing spondylitis	0.000166	0.000627	CcSEcCtD
Fluvoxamine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000166	0.000626	CcSEcCtD
Fluvoxamine—Tachycardia—Prednisone—ankylosing spondylitis	0.000165	0.000623	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000163	0.000617	CcSEcCtD
Fluvoxamine—Vision blurred—Methotrexate—ankylosing spondylitis	0.000163	0.000616	CcSEcCtD
Fluvoxamine—Anorexia—Prednisone—ankylosing spondylitis	0.000161	0.000608	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00016	0.000606	CcSEcCtD
Fluvoxamine—Anaemia—Methotrexate—ankylosing spondylitis	0.00016	0.000604	CcSEcCtD
Fluvoxamine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00016	0.000604	CcSEcCtD
Fluvoxamine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00016	0.000604	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000159	0.000599	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000159	0.000599	CcSEcCtD
Fluvoxamine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000157	0.000595	CcSEcCtD
Fluvoxamine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000157	0.000594	CcSEcCtD
Fluvoxamine—Malaise—Methotrexate—ankylosing spondylitis	0.000156	0.000589	CcSEcCtD
Fluvoxamine—Vertigo—Methotrexate—ankylosing spondylitis	0.000155	0.000587	CcSEcCtD
Fluvoxamine—Leukopenia—Methotrexate—ankylosing spondylitis	0.000155	0.000585	CcSEcCtD
Fluvoxamine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000154	0.000582	CcSEcCtD
Fluvoxamine—Urticaria—Betamethasone—ankylosing spondylitis	0.000154	0.000582	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000154	0.000582	CcSEcCtD
Fluvoxamine—Dizziness—Prednisolone—ankylosing spondylitis	0.000154	0.000581	CcSEcCtD
Fluvoxamine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000153	0.00058	CcSEcCtD
Fluvoxamine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000153	0.000579	CcSEcCtD
Fluvoxamine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000153	0.000579	CcSEcCtD
Fluvoxamine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000153	0.000579	CcSEcCtD
Fluvoxamine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000153	0.000579	CcSEcCtD
Fluvoxamine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000153	0.000578	CcSEcCtD
Fluvoxamine—Insomnia—Prednisone—ankylosing spondylitis	0.000153	0.000577	CcSEcCtD
Fluvoxamine—Paraesthesia—Prednisone—ankylosing spondylitis	0.000152	0.000573	CcSEcCtD
Fluvoxamine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000151	0.000572	CcSEcCtD
Fluvoxamine—Cough—Methotrexate—ankylosing spondylitis	0.000151	0.00057	CcSEcCtD
Fluvoxamine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000151	0.00057	CcSEcCtD
Fluvoxamine—Convulsion—Methotrexate—ankylosing spondylitis	0.00015	0.000566	CcSEcCtD
Fluvoxamine—Dyspepsia—Prednisone—ankylosing spondylitis	0.000149	0.000562	CcSEcCtD
Fluvoxamine—Chest pain—Methotrexate—ankylosing spondylitis	0.000147	0.000556	CcSEcCtD
Fluvoxamine—Myalgia—Methotrexate—ankylosing spondylitis	0.000147	0.000556	CcSEcCtD
Fluvoxamine—Arthralgia—Methotrexate—ankylosing spondylitis	0.000147	0.000556	CcSEcCtD
Fluvoxamine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000147	0.000555	CcSEcCtD
Fluvoxamine—Rash—Prednisolone—ankylosing spondylitis	0.000146	0.000554	CcSEcCtD
Fluvoxamine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000146	0.000553	CcSEcCtD
Fluvoxamine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000146	0.000551	CcSEcCtD
Fluvoxamine—Fatigue—Prednisone—ankylosing spondylitis	0.000146	0.00055	CcSEcCtD
Fluvoxamine—Headache—Prednisolone—ankylosing spondylitis	0.000146	0.00055	CcSEcCtD
Fluvoxamine—Discomfort—Methotrexate—ankylosing spondylitis	0.000145	0.00055	CcSEcCtD
Fluvoxamine—Constipation—Prednisone—ankylosing spondylitis	0.000144	0.000546	CcSEcCtD
Fluvoxamine—Confusional state—Methotrexate—ankylosing spondylitis	0.000142	0.000538	CcSEcCtD
Fluvoxamine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000141	0.000534	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000141	0.000533	CcSEcCtD
Fluvoxamine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000141	0.000533	CcSEcCtD
Fluvoxamine—Infection—Methotrexate—ankylosing spondylitis	0.00014	0.00053	CcSEcCtD
Fluvoxamine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000139	0.000526	CcSEcCtD
Fluvoxamine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000139	0.000526	CcSEcCtD
Fluvoxamine—Asthenia—Betamethasone—ankylosing spondylitis	0.000139	0.000526	CcSEcCtD
Fluvoxamine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000138	0.000523	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000138	0.000522	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000138	0.000522	CcSEcCtD
Fluvoxamine—Nausea—Prednisolone—ankylosing spondylitis	0.000138	0.000522	CcSEcCtD
Fluvoxamine—Pruritus—Betamethasone—ankylosing spondylitis	0.000137	0.000519	CcSEcCtD
Fluvoxamine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000137	0.000519	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000136	0.000516	CcSEcCtD
Fluvoxamine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000136	0.000514	CcSEcCtD
Fluvoxamine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000136	0.000512	CcSEcCtD
Fluvoxamine—Rash—Triamcinolone—ankylosing spondylitis	0.000135	0.000509	CcSEcCtD
Fluvoxamine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000135	0.000509	CcSEcCtD
Fluvoxamine—Anorexia—Methotrexate—ankylosing spondylitis	0.000134	0.000509	CcSEcCtD
Fluvoxamine—Rash—Methylprednisolone—ankylosing spondylitis	0.000134	0.000508	CcSEcCtD
Fluvoxamine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000134	0.000508	CcSEcCtD
Fluvoxamine—Urticaria—Prednisone—ankylosing spondylitis	0.000134	0.000507	CcSEcCtD
Fluvoxamine—Headache—Triamcinolone—ankylosing spondylitis	0.000134	0.000506	CcSEcCtD
Fluvoxamine—Headache—Methylprednisolone—ankylosing spondylitis	0.000134	0.000505	CcSEcCtD
Fluvoxamine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000133	0.000505	CcSEcCtD
Fluvoxamine—Abdominal pain—Prednisone—ankylosing spondylitis	0.000133	0.000505	CcSEcCtD
Fluvoxamine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000133	0.000502	CcSEcCtD
Fluvoxamine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000133	0.000502	CcSEcCtD
Fluvoxamine—Hypotension—Methotrexate—ankylosing spondylitis	0.000132	0.000498	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000129	0.000486	CcSEcCtD
Fluvoxamine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000128	0.000485	CcSEcCtD
Fluvoxamine—Dizziness—Betamethasone—ankylosing spondylitis	0.000128	0.000485	CcSEcCtD
Fluvoxamine—Insomnia—Methotrexate—ankylosing spondylitis	0.000128	0.000483	CcSEcCtD
Fluvoxamine—Nausea—Triamcinolone—ankylosing spondylitis	0.000127	0.00048	CcSEcCtD
Fluvoxamine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000127	0.000479	CcSEcCtD
Fluvoxamine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000127	0.000479	CcSEcCtD
Fluvoxamine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000126	0.000476	CcSEcCtD
Fluvoxamine—Somnolence—Methotrexate—ankylosing spondylitis	0.000125	0.000474	CcSEcCtD
Fluvoxamine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000124	0.00047	CcSEcCtD
Fluvoxamine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000124	0.00047	CcSEcCtD
Fluvoxamine—Vomiting—Betamethasone—ankylosing spondylitis	0.000123	0.000466	CcSEcCtD
Fluvoxamine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000123	0.000466	CcSEcCtD
Fluvoxamine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000123	0.000464	CcSEcCtD
Fluvoxamine—Rash—Dexamethasone—ankylosing spondylitis	0.000122	0.000462	CcSEcCtD
Fluvoxamine—Rash—Betamethasone—ankylosing spondylitis	0.000122	0.000462	CcSEcCtD
Fluvoxamine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000122	0.000462	CcSEcCtD
Fluvoxamine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000122	0.000462	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000122	0.000461	CcSEcCtD
Fluvoxamine—Fatigue—Methotrexate—ankylosing spondylitis	0.000122	0.00046	CcSEcCtD
Fluvoxamine—Headache—Betamethasone—ankylosing spondylitis	0.000121	0.000459	CcSEcCtD
Fluvoxamine—Headache—Dexamethasone—ankylosing spondylitis	0.000121	0.000459	CcSEcCtD
Fluvoxamine—Asthenia—Prednisone—ankylosing spondylitis	0.000121	0.000458	CcSEcCtD
Fluvoxamine—Pain—Methotrexate—ankylosing spondylitis	0.000121	0.000456	CcSEcCtD
Fluvoxamine—Pruritus—Prednisone—ankylosing spondylitis	0.000119	0.000452	CcSEcCtD
Fluvoxamine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000116	0.00044	CcSEcCtD
Fluvoxamine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000115	0.000437	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000115	0.000436	CcSEcCtD
Fluvoxamine—Nausea—Betamethasone—ankylosing spondylitis	0.000115	0.000435	CcSEcCtD
Fluvoxamine—Nausea—Dexamethasone—ankylosing spondylitis	0.000115	0.000435	CcSEcCtD
Fluvoxamine—Urticaria—Methotrexate—ankylosing spondylitis	0.000112	0.000424	CcSEcCtD
Fluvoxamine—Dizziness—Prednisone—ankylosing spondylitis	0.000112	0.000422	CcSEcCtD
Fluvoxamine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000112	0.000422	CcSEcCtD
Fluvoxamine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000112	0.000422	CcSEcCtD
Fluvoxamine—Vomiting—Prednisone—ankylosing spondylitis	0.000107	0.000406	CcSEcCtD
Fluvoxamine—Rash—Prednisone—ankylosing spondylitis	0.000106	0.000402	CcSEcCtD
Fluvoxamine—Dermatitis—Prednisone—ankylosing spondylitis	0.000106	0.000402	CcSEcCtD
Fluvoxamine—Headache—Prednisone—ankylosing spondylitis	0.000106	0.0004	CcSEcCtD
Fluvoxamine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000104	0.000393	CcSEcCtD
Fluvoxamine—Asthenia—Methotrexate—ankylosing spondylitis	0.000101	0.000383	CcSEcCtD
Fluvoxamine—Nausea—Prednisone—ankylosing spondylitis	0.0001	0.000379	CcSEcCtD
Fluvoxamine—Pruritus—Methotrexate—ankylosing spondylitis	9.98e-05	0.000377	CcSEcCtD
Fluvoxamine—Diarrhoea—Methotrexate—ankylosing spondylitis	9.65e-05	0.000365	CcSEcCtD
Fluvoxamine—Dizziness—Methotrexate—ankylosing spondylitis	9.33e-05	0.000353	CcSEcCtD
Fluvoxamine—Vomiting—Methotrexate—ankylosing spondylitis	8.97e-05	0.000339	CcSEcCtD
Fluvoxamine—Rash—Methotrexate—ankylosing spondylitis	8.9e-05	0.000336	CcSEcCtD
Fluvoxamine—Dermatitis—Methotrexate—ankylosing spondylitis	8.89e-05	0.000336	CcSEcCtD
Fluvoxamine—Headache—Methotrexate—ankylosing spondylitis	8.84e-05	0.000334	CcSEcCtD
Fluvoxamine—Nausea—Methotrexate—ankylosing spondylitis	8.38e-05	0.000317	CcSEcCtD
